- The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myeloma. Uyl-de Groot, C.A., Ossenkoppele, G.J., van Riet, A.A., Rutten, F.F. Eur. J. Cancer (1994)